Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVI-DROPS in Outpatient Adults With COVID-19
NCT04906694Phase 2Completed
- Sponsor
- Sorrento Therapeutics
- Start
- Nov 2021
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of STI-2099 in coronavirus disease 2019 (COVID-19), sponsored by Sorrento Therapeutics. Started Nov 2021; status: completed.
02
Drugs
STI-2099
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04906694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906694.